Outcomes of critically ill patients with newly diagnosed Burkitt’s lymphoma: a monocentric retrospective study
Fabiola Cammarota, Charlotte Degoutte, Laure Calvet, Dara Chean, Claire Fieschi, Catherine Thieblemont, Gennaro De Pascale, Michael Darmon, Lara Zafrani, Massimo Antonelli, Elie Azoulay, Thibault Dupont · 2026
Read Outcomes of critically ill patients with newly diagnosed Burkitt’s lymphoma: a monocentric retrospective study by Fabiola Cammarota, Charlotte Degoutte, Laure Calvet, Dara Chean, Claire Fieschi, Catherine Thieblemont, Gennaro De Pascale, Michael Darmon, Lara Zafrani, Massimo Antonelli, Elie Azoulay, Thibault Dupont (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13218120.txt.
Description
Fabiola Cammarota and colleagues report outcomes of critically ill patients with newly diagnosed Burkitt's lymphoma at one Paris hospital. Their 2026 retrospective study covers intensive care admissions over two decades for this fast-growing cancer.
One hundred twenty-four patients were admitted, most with advanced disease and sixty percent living with HIV. Most received chemotherapy during the intensive care stay, and nearly sixty percent developed tumour lysis syndrome. Ninety-day mortality was about a third; one-year mortality reached half. Nearly all one-year survivors achieved complete remission, and most had good functional status. Tumour lysis, blood pressure drugs, HIV, male sex, and age independently predicted one-year death.
Catalog record
| CREATOR | Fabiola Cammarota, Charlotte Degoutte, Laure Calvet, Dara Chean, Claire Fieschi, Catherine Thieblemont, Gennaro De Pascale, Michael Darmon, Lara Zafrani, Massimo Antonelli, Elie Azoulay, Thibault Dupont |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |